GB0419627D0 - Immunogenic bacterial vesicles with outer membrane proteins - Google Patents

Immunogenic bacterial vesicles with outer membrane proteins

Info

Publication number
GB0419627D0
GB0419627D0 GBGB0419627.5A GB0419627A GB0419627D0 GB 0419627 D0 GB0419627 D0 GB 0419627D0 GB 0419627 A GB0419627 A GB 0419627A GB 0419627 D0 GB0419627 D0 GB 0419627D0
Authority
GB
United Kingdom
Prior art keywords
outer membrane
membrane proteins
bacterial vesicles
immunogenic bacterial
immunogenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0419627.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GSK Vaccines SRL
Original Assignee
Chiron SRL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiron SRL filed Critical Chiron SRL
Priority to GBGB0419627.5A priority Critical patent/GB0419627D0/en
Publication of GB0419627D0 publication Critical patent/GB0419627D0/en
Priority to EP05782411.2A priority patent/EP1784213B1/en
Priority to US11/661,996 priority patent/US8808711B2/en
Priority to MX2007002633A priority patent/MX2007002633A/es
Priority to ES05782411.2T priority patent/ES2527859T3/es
Priority to PCT/IB2005/002801 priority patent/WO2006024946A2/en
Priority to AU2005278896A priority patent/AU2005278896B2/en
Priority to CA002578588A priority patent/CA2578588A1/en
Priority to BRPI0514883-9A priority patent/BRPI0514883A/pt
Priority to JP2007529033A priority patent/JP2008511608A/ja
Priority to CNA2005800294697A priority patent/CN101115501A/zh
Priority to RU2007111838/15A priority patent/RU2420312C2/ru
Priority to NZ553521A priority patent/NZ553521A/en
Priority to CN201010169356A priority patent/CN101862451A/zh
Priority to JP2011185225A priority patent/JP2011236254A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
GBGB0419627.5A 2004-09-03 2004-09-03 Immunogenic bacterial vesicles with outer membrane proteins Ceased GB0419627D0 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
GBGB0419627.5A GB0419627D0 (en) 2004-09-03 2004-09-03 Immunogenic bacterial vesicles with outer membrane proteins
CN201010169356A CN101862451A (zh) 2004-09-03 2005-09-05 涉及脑膜炎球菌外膜囊泡的改进
AU2005278896A AU2005278896B2 (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles
BRPI0514883-9A BRPI0514883A (pt) 2004-09-03 2005-09-05 melhoramentos relacionados a vesìculas de membrana exteriores de meningocócico
MX2007002633A MX2007002633A (es) 2004-09-03 2005-09-05 Mejoras con relacion a vesiculas meningococales de membrana exterior.
ES05782411.2T ES2527859T3 (es) 2004-09-03 2005-09-05 Mejoras referentes a vesículas de membrana externa meningocócicas
PCT/IB2005/002801 WO2006024946A2 (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles
EP05782411.2A EP1784213B1 (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles
CA002578588A CA2578588A1 (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles
US11/661,996 US8808711B2 (en) 2004-09-03 2005-09-05 Meningococcal outer membrane vesicles
JP2007529033A JP2008511608A (ja) 2004-09-03 2005-09-05 髄膜炎菌外膜ベシクルに関する改良
CNA2005800294697A CN101115501A (zh) 2004-09-03 2005-09-05 涉及脑膜炎球菌外膜囊泡的改进
RU2007111838/15A RU2420312C2 (ru) 2004-09-03 2005-09-05 Усовершенствования, касающиеся везикул внешней мембраны менингококков
NZ553521A NZ553521A (en) 2004-09-03 2005-09-05 Improvements relating to meningococcal outer membrane vesicles and their use in vaccines
JP2011185225A JP2011236254A (ja) 2004-09-03 2011-08-26 髄膜炎菌外膜ベシクルに関する改良

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0419627.5A GB0419627D0 (en) 2004-09-03 2004-09-03 Immunogenic bacterial vesicles with outer membrane proteins

Publications (1)

Publication Number Publication Date
GB0419627D0 true GB0419627D0 (en) 2004-10-06

Family

ID=33156002

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0419627.5A Ceased GB0419627D0 (en) 2004-09-03 2004-09-03 Immunogenic bacterial vesicles with outer membrane proteins

Country Status (13)

Country Link
US (1) US8808711B2 (enExample)
EP (1) EP1784213B1 (enExample)
JP (2) JP2008511608A (enExample)
CN (2) CN101115501A (enExample)
AU (1) AU2005278896B2 (enExample)
BR (1) BRPI0514883A (enExample)
CA (1) CA2578588A1 (enExample)
ES (1) ES2527859T3 (enExample)
GB (1) GB0419627D0 (enExample)
MX (1) MX2007002633A (enExample)
NZ (1) NZ553521A (enExample)
RU (1) RU2420312C2 (enExample)
WO (1) WO2006024946A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513371D0 (en) * 1995-06-30 1995-09-06 Biocine Spa Immunogenic detoxified mutant toxins
EP1860191A3 (en) 1999-05-19 2008-02-13 Novartis Vaccines and Diagnostics S.r.l. Combination neisserial compositions
GB9928196D0 (en) 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0424092D0 (en) 2004-10-29 2004-12-01 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
US10828361B2 (en) * 2006-03-22 2020-11-10 Glaxosmithkline Biologicals Sa Regimens for immunisation with meningococcal conjugates
CA2646993C (en) 2006-03-22 2016-01-26 Novartis Ag Regimens for immunisation with meningococcal conjugates
NZ584683A (en) 2007-10-19 2012-05-25 Novartis Ag Neisseria meningitidis serogroup B vaccine formulations
PL2268618T3 (pl) 2008-03-03 2015-11-30 Novartis Ag Związki i kompozycje jako modulatory aktywności receptorów TLR
US9387239B2 (en) * 2008-05-30 2016-07-12 U.S. Army Medical Research And Materiel Command Meningococcal multivalent native outer membrane vesicle vaccine, methods of making and use thereof
GB0822634D0 (en) * 2008-12-11 2009-01-21 Novartis Ag Meningitis vaccines
BRPI0923006A2 (pt) 2008-12-17 2016-03-08 Novartis Ag vacinas meningococicas incluindo receptor de hemoglobina
CN102762226A (zh) 2009-06-10 2012-10-31 诺华有限公司 含苯并萘啶的疫苗
CN102740882A (zh) 2009-08-27 2012-10-17 诺华有限公司 含有铝、寡核苷酸和聚阳离子的佐剂
JO3257B1 (ar) 2009-09-02 2018-09-16 Novartis Ag مركبات وتركيبات كمعدلات لفاعلية tlr
ES2443952T3 (es) 2009-09-02 2014-02-21 Novartis Ag Composiciones inmunógenas que incluyen moduladores de la actividad de TLR
WO2011057148A1 (en) 2009-11-05 2011-05-12 Irm Llc Compounds and compositions as tlr-7 activity modulators
US9408907B2 (en) 2009-12-15 2016-08-09 Glaxosmithkline Biologicals Sa Homogenous suspension of immunopotentiating compounds and uses thereof
WO2012020326A1 (en) 2010-03-18 2012-02-16 Novartis Ag Adjuvanted vaccines for serogroup b meningococcus
JP5848748B2 (ja) 2010-03-23 2016-01-27 アイアールエム・リミテッド・ライアビリティ・カンパニーＩｒｍ，Ｌｌｃ 感染症、炎症、呼吸器疾患などの処置に使用するｔｌｒ２アゴニストとしての化合物（システインベースのリポペプチド）および組成物
AU2011300418B2 (en) 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom
WO2012153302A1 (en) 2011-05-12 2012-11-15 Novartis Ag Antipyretics to enhance tolerability of vesicle-based vaccines
MX2014008988A (es) 2012-02-02 2014-08-27 Novartis Ag Promotores para aumento de expresion de proteinas en meningococo.
US10598666B2 (en) 2012-03-08 2020-03-24 Glaxosmithkline Biologicals Sa In vitro potency assay for protein-based meningococcal vaccines
EP2833911A4 (en) 2012-04-06 2016-07-13 Univ Cornell SUB-VACCINE VACCINATING PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
US10376573B2 (en) 2012-06-14 2019-08-13 Glaxosmithkline Biologicals Sa Vaccines for serogroup X meningococcus
RU2015106930A (ru) 2012-09-06 2016-10-20 Новартис Аг Комбинированные вакцины с менингококком серогруппы в и к/д/с
RU2662970C2 (ru) 2012-09-18 2018-07-31 Новартис Аг Везикулы наружной мембраны
US20160120818A1 (en) 2013-02-07 2016-05-05 Glaxosmithline Biological Sa Pharmaceutical compositions comprising vesicles
CA2940447C (en) 2014-02-28 2023-07-11 Glaxosmithkline Biologicals Sa Modified meningococcal fhbp polypeptides
EA201692552A1 (ru) 2014-07-17 2017-06-30 Глаксосмитклайн Байолоджикалс С.А. МОДИФИЦИРОВАННЫЕ МЕНИНГОКОККОВЫЕ ПОЛИПЕПТИДЫ fHbp
AR101225A1 (es) 2014-07-17 2016-11-30 Glaxosmithkline Biologicals Sa Vacunas de meningococos
KR101742236B1 (ko) * 2014-10-29 2017-05-31 인하대학교 산학협력단 쯔쯔가무시병에 대한 면역 조성물 및 이의 제조방법
CN105669964B (zh) * 2016-03-04 2017-11-21 博瑞生物医药（苏州）股份有限公司 卵巢癌特异靶向的生物可降解双亲性聚合物、由其制备的聚合物囊泡及应用
JP7104027B2 (ja) 2016-09-02 2022-07-20 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 淋菌に対するワクチン
AR113011A1 (es) 2017-09-08 2020-01-15 Evelo Biosciences Inc Vesículas extracelulares bacterianas
GB202115077D0 (en) 2021-10-21 2021-12-08 Glaxosmithkline Biologicals Sa Assay

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2848965A1 (de) 1978-11-11 1980-05-22 Behringwerke Ag Verfahren zur herstellung von membranproteinen aus neisseria meningitidis und diese enthaltende vaccine
ES2145072T3 (es) * 1993-05-13 2000-07-01 American Cyanamid Co Preparacion y usos de proteinas de membranas externas carentes de los de cocos gramnegativos.
ES2128055T3 (es) * 1994-04-20 1999-05-01 Us Army Vacuna contra infecciones de bacterias gram-negativas.
US6180111B1 (en) * 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
AU748973B2 (en) * 1997-07-17 2002-06-13 Baxter Healthcare Sa Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharide
EP1741443B1 (en) 1998-05-29 2014-05-21 Novartis Vaccines and Diagnostics, Inc. Combination meningitidis B/C vaccines
ES2278446T3 (es) 1998-05-29 2007-08-01 Novartis Vaccines And Diagnostics, Inc. Vacunas combinadas b/c contra la meningitis.
GB9918319D0 (en) * 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
AU1917501A (en) 1999-11-12 2001-06-06 University Of Iowa Research Foundation, The Control of neisserial membrane synthesis
NO20002828D0 (no) 2000-06-02 2000-06-02 Statens Inst For Folkehelse Proteinholdig vaksine mot Neisseria meningtidis serogruppe samt fremgangsmÕte ved fremstilling derav
ES2519440T3 (es) * 2000-07-27 2014-11-07 Children's Hospital & Research Center At Oakland Vacunas para la protección de amplio espectro contra enfermedades causadas por Neisseria meningitidis
WO2003009869A1 (en) * 2001-07-26 2003-02-06 Chiron Srl. Vaccines comprising aluminium adjuvants and histidine
GB0130123D0 (en) * 2001-12-17 2002-02-06 Microbiological Res Agency Outer membrane vesicle vaccine and its preparation
GB0213622D0 (en) * 2002-06-13 2002-07-24 Glaxosmithkline Biolog Sa Vaccine Corporation
DK2255826T3 (en) 2002-08-02 2016-06-20 Glaxosmithkline Biologicals Sa Neisserial vaccine compositions comprising a combination of antigens.
GB0220194D0 (en) 2002-08-30 2002-10-09 Chiron Spa Improved vesicles
GB0227346D0 (en) * 2002-11-22 2002-12-31 Chiron Spa 741
WO2004054611A1 (en) * 2002-12-16 2004-07-01 Nasjonalt Folkehelseinstitutt Meningococcal vaccine based on outer membrane proteins porb2 and pora
US7031284B2 (en) * 2003-03-03 2006-04-18 Interdigital Technology Corporation Wireless communication method and apparatus for optimizing multi-user detection
GB0316560D0 (en) 2003-07-15 2003-08-20 Chiron Srl Vesicle filtration
US7628995B2 (en) 2003-12-23 2009-12-08 Glaxosmithkline Biologicals S.A. Outer membrane vesicles and uses thereof
US20090246224A1 (en) * 2006-06-12 2009-10-01 Nathalie Devos Vaccine

Also Published As

Publication number Publication date
NZ553521A (en) 2010-01-29
EP1784213A2 (en) 2007-05-16
US8808711B2 (en) 2014-08-19
CN101115501A (zh) 2008-01-30
WO2006024946A3 (en) 2006-11-30
AU2005278896B2 (en) 2011-12-22
RU2420312C2 (ru) 2011-06-10
ES2527859T3 (es) 2015-01-30
US20080063665A1 (en) 2008-03-13
CA2578588A1 (en) 2006-03-09
MX2007002633A (es) 2007-05-15
JP2008511608A (ja) 2008-04-17
AU2005278896A1 (en) 2006-03-09
CN101862451A (zh) 2010-10-20
EP1784213B1 (en) 2014-10-29
BRPI0514883A (pt) 2008-06-24
WO2006024946A2 (en) 2006-03-09
RU2007111838A (ru) 2008-10-10
JP2011236254A (ja) 2011-11-24

Similar Documents

Publication Publication Date Title
GB0419627D0 (en) Immunogenic bacterial vesicles with outer membrane proteins
AP2008004615A0 (en) Virosome-like vesicles comprising GP-41 derived antigens
IL179311A0 (en) Membrane bioreactor
ZA200703445B (en) Nanoparticulated whey proteins
EP1789094A4 (en) BACTERIAL DELIVERY SYSTEM
IL176692A0 (en) Membrane scaffold proteins
AU2006272804A8 (en) Concentrated protein lyophilates, methods, and uses
WO2007053655A3 (en) Cell-free synthesis of membrane bound polypeptides
PL1704287T3 (pl) Folia kubełkowa
EP1731172A4 (en) PREPARATION OF LIPOSOME
AU2003288558A1 (en) Meningococcal vaccine based on outer membrane proteins porb2 and pora
WO2007102946A3 (en) Crystalline polypeptides
SI1534326T1 (sl) Izboljĺ ani bakterijski zunaj membranski vezikli
GB0413968D0 (en) Integral membrane protein
GB0420962D0 (en) Integral membrane protein
AU2005903721A0 (en) Bacterial proteins
AU2004902629A0 (en) Membrane Bioreactor
AU2003903953A0 (en) Composite membranes
HK1098664A (en) Improvements in vaccination
HK1110862A (en) Antigenic peptides and their use
AU2004906947A0 (en) Membrane post treatment
HK1106775A (en) Hk1-binding proteins
AU2004907195A0 (en) Bacterial Biocementation
GB0301473D0 (en) Improvements in membrane securing means
AU2004900826A0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)